PRKCB and osteosarcoma: In this study, we found that CXCL13 facilitates PLCβ, PKCβ, and c-Src phosphorylation, while PLCβ, PKCα, and c-Src inhibitors reduce CXCL13-induced stimulation of VCAM-1 production and osteosarcoma cell migration.